Article Details

Genting-backed biotech firm completes first assessment of Covid-19 treatment trial

Retrieved on: 2020-12-13 10:07:30

Tags for this article:

Click the tags to see associated articles and topics

Genting-backed biotech firm completes first assessment of Covid-19 treatment trial. View article details on hiswai:

Excerpt

KUALA LUMPUR (Dec 13): Genting Bhd's <b>biotechnology</b> arm Celularity Inc said its independent data monitoring committee (DMC) had completed the ...

Article found on: www.theedgemarkets.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo